Dombroski R, Casey M L, Macdonald P C
Department of Obstetrics-Gynecology, University of Texas Southwestern Medical School, Dallas 75235, USA.
J Clin Endocrinol Metab. 1997 May;82(5):1338-44. doi: 10.1210/jcem.82.5.3908.
This study was conducted to evaluate further the reaction catalyzed by the saturated steroid 6alpha-hydroxylase of extrahepatic human tissues. Progesterone and 5alpha-dihydroprogesterone (5alpha-DHP) are plasma-borne precursors of 5alpha-pregnan-3alpha-ol-20-one, an anxiolytic/anesthetic steroid, and 5alpha-pregnan-3beta-ol-20-one in extrahepatic human tissues. These two steroids are metabolized further by a saturated steroid 6alpha-hydroxylase enzyme(s) that is distinct from the cytochrome P450 6alpha-hydroxylase that catalyzes the 6alpha-hydroxylation of delta4-3-ketosteroids such as progesterone, cortisol, and testosterone. Products of this saturated steroid 6alpha-hydroxylase, viz. 3beta/alpha,6alpha-dihydroxy-5alpha-pregnan-20-ones, are major radiolabeled urinary metabolites (excreted as glucuronosides) of i.v. administered tritium-labeled 5alpha-DHP in women and men. T47-D human breast cancer cells, which are rich in saturated steroid 6alpha-hydroxylase activity, were used as the enzyme source in this study. The greatest total and the highest specific activity of saturated steroid 6alpha-hydroxylase were localized in microsome-enriched preparations; enzyme activity was linear with incubation time up to 30 min and with microsome-enriched tissue protein concentrations between 0.05-0.5 mg/mL incubation mixture. The velocity of the reaction was similar in incubations in which the pH was varied from 6.0-8.0, and NADH and NADPH were equally effective in supporting the 6alpha-hydroxylation of 5alpha-pregnan-3beta-ol-20-one and 5alpha-pregnan-3alpha-ol-20-one. The more efficient substrates for this enzyme were 5alpha-pregnan-3beta-ol-20-one and 5alpha-pregnan-3alpha-ol-20-one, and the apparent Km (approximately 3.5 micromol/L) and maximum velocity (approximately 150 pmol/min x mg microsome-enriched protein) for these two substrates were indistinguishable. 5alpha-Androstane-3beta,17beta-diol was less efficiently 6alpha-hydroxylated, and 5alpha-androstane-3alpha,17beta-diol was an inefficient substrate. The addition of a variety of inhibitors of cytochrome P450 monooxygenases to the incubation mixtures did not diminish significantly the 6alpha-hydroxylation of 5alpha-pregnan-3beta-ol-20-one, findings consistent with those of other investigators who suggested that human saturated steroid 6alpha-hydroxylase (of human prostate) is not a cytochrome P450.
本研究旨在进一步评估人肝外组织中饱和类固醇6α-羟化酶催化的反应。孕酮和5α-二氢孕酮(5α-DHP)是5α-孕烷-3α-醇-20-酮(一种抗焦虑/麻醉类固醇)和人肝外组织中5α-孕烷-3β-醇-20-酮的血浆携带前体。这两种类固醇可被一种饱和类固醇6α-羟化酶进一步代谢,该酶与催化孕酮、皮质醇和睾酮等δ4-3-酮类固醇6α-羟化的细胞色素P450 6α-羟化酶不同。这种饱和类固醇6α-羟化酶的产物,即3β/α,6α-二羟基-5α-孕烷-20-酮,是静脉注射氚标记的5α-DHP在男性和女性中主要的放射性标记尿代谢物(以葡萄糖醛酸苷形式排泄)。富含饱和类固醇6α-羟化酶活性的T47-D人乳腺癌细胞被用作本研究的酶源。饱和类固醇6α-羟化酶的最大总活性和最高比活性定位于富含微粒体的制剂中;酶活性在长达30分钟的孵育时间内呈线性,在孵育混合物中富含微粒体的组织蛋白浓度为0.05 - 0.5 mg/mL时也呈线性。在pH值从6.0 - 8.0变化的孵育中,反应速度相似,NADH和NADPH在支持5α-孕烷-3β-醇-20-酮和5α-孕烷-3α-醇-20-酮的6α-羟化方面同样有效。该酶更有效的底物是5α-孕烷-3β-醇-20-酮和5α-孕烷-3α-醇-20-酮,这两种底物的表观Km(约3.5 μmol/L)和最大速度(约150 pmol/min x mg富含微粒体的蛋白)没有差异。5α-雄甾烷-3β,17β-二醇的6α-羟化效率较低,5α-雄甾烷-3α,17β-二醇是一种低效底物。向孵育混合物中添加多种细胞色素P450单加氧酶抑制剂并没有显著降低5α-孕烷-3β-醇-20-酮的6α-羟化,这一发现与其他研究者的结果一致,他们认为(人前列腺的)人饱和类固醇6α-羟化酶不是细胞色素P450。